Description of the goods or services required
Coronavirus rapid response call - Diagnosing and understanding coronavirus
The Department of Health and Social Care, through the NIHR, and UK Research and Innovation (UKRI) have jointly launched two rapid response research calls to tackle the 2019 novel coronavirus (2019-nCoV).
The second call invites applications for UK-led academic, small- and medium-sized enterprise (SME) and wider industry research that will develop diagnostics or address the epidemiology, spread, containment or underpinning knowledge of 2019-nCoV.
Short term (up to 18 month) proposals are sought that could make a significant contribution to the understanding, diagnosis, prevention and/or management of the 2019-nCoV outbreak.
The scope for this call encompasses:
•Diagnostics research, including: ◦Development and performance studies of genetic and serological 2019-nCoV diagnostic tests
•Clinical research, including: ◦Clinical investigations aimed at understanding the natural history of disease
•Epidemiological research, including: ◦Animal and environmental investigations to identify the zoonotic source of 2019-nCoV
◦Epidemiologic and sero-epidemiologic investigations, such as those aimed to better understand transmission characteristics and severity of 2019-nCoV, including those investigating viral shedding
◦Epidemiological or evolutionary models to better understand transmission, predict spread, and evaluate the potential impact of control measures
•Anthropology and wider social sciences research, including: ◦Social science that contributes to understanding and influencing behavior (for the public, institutions and workplaces) to facilitate containment and minimise counterproductive behaviours
◦Collection of knowledge, perceptions, behaviours and exposures of people affected or at risk of 2019-nCoV infection.
•Underpinning research - development of novel technologies, platforms or systems to accelerate the R&D of diagnostics, vaccines and therapeutics, and epidemiological studies. Including: ◦Research that supports/enables vaccine and diagnostic development e.g. reagents and standards
◦Development of suitable neutralisation assays and animal challenge models.
•Other research projects that would make a significant contribution to the understanding, diagnosis, prevention and/or management of the 2019-nCoV outbreak.